Intranasal live cold-adapted influenza vaccine: Update

The trial, which studied children ranging in age from 15 months to 6 years, gave 1,300 children

Read the full 171 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE